Risk of piperacillin‐induced hemolytic anemia in patients with cystic fibrosis and antipseudomonal treatment: a prospective observational study-Reference-Cited by-同舟云学术

Risk of piperacillin‐induced hemolytic anemia in patients with cystic fibrosis and antipseudomonal treatment: a prospective observational study

Published:2019-11-14 Issue:12 Volume:59 Page:3746-3754
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Roehmel Jobst¹,Specht Philip¹,Staab Doris¹,Schwarz Carsten¹,Salama Abdulgabar²,Mayer Beate³^ORCID

Affiliation:

1. Department of Pediatric Pneumology, Immunology and Intensive Care Medicine ‐ Division of Cystic FibrosisCharité‐Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt‐Universität zu Berlin, and Berlin Institute of Health Berlin Germany

2. Department of GynecologyCharité‐Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt‐Universität zu Berlin, and Berlin Institute of Health Berlin Germany

3. Institute of Transfusion MedicineCharité‐Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt‐Universität zu Berlin, and Berlin Institute of Health Berlin Germany

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.15591

Reference58 articles.

1. Drug induced immune haemolytic anaemia in the Berlin Case-Control Surveillance Study

2. Diagnostic pitfalls of drug‐induced immune hemolytic anemia;Salama A;Immunohematology,2014

3. Drugs that have been shown to cause drug‐induced immune hemolytic anemia or positive direct antiglobulin tests: some interesting findings since 2007;Garratty G;Immunohematology,2014

4. Drug-Induced Immune Cytopenias: A Unifying Pathogenetic Concept With Special Emphasis on the Role of Drug Metabolites

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lymphocyte transformation tests predict delayed-type allergy to piperacillin/tazobactam in patients with cystic fibrosis;Journal of Cystic Fibrosis;2023-12

2. A Real-World Disproportionality Analysis of Drug-Induced Immune Hemolytic Anemia in the FDA Adverse Event Reporting System;Annals of Pharmacotherapy;2023-07-31

3. In macrohematuria, medication history also needs to be considered;Die Innere Medizin;2023-07-26

4. Piperacillin-tazobactam induced immune hemolytic anemia led to increased renal impairment and eventual death from multiple organ failure in a patient with hypertensive nephropathy: case report and literature review;BMC Nephrology;2023-06-14

5. Medikamentös induzierte Immunhämolysen;Transfusionsmedizin;2023-05